Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBk. Cyprus Hldg Regulatory News (BOCH)

Share Price Information for Bk. Cyprus Hldg (BOCH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 320.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 1.00 (0.312%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 320.00
BOCH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Agreement for the sale of investment in CNP Cyprus

4 Jun 2019 07:30

RNS Number : 0481B
Bank of Cyprus Holdings PLC
04 June 2019
 

Announcement

 

Agreement for the sale of investment in CNP Cyprus Insurance Holdings Ltd

 

Nicosia, 4 June 2019

 

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014.

 

 

Bank of Cyprus Holdings Public Limited Company ("BOC Holdings" and, together with its subsidiaries, the "Group") announces that it has signed a binding agreement to sell its entire shareholding of 49.9% in its associate CNP Cyprus Insurance Holdings Limited ("CNP CIH") that had been acquired as part of the acquisition of certain operations of Laiki Bank in 2013, to CNP Assurances S. A. (the "Buyer"), who currently owns the remaining 50.1% and is the controlling party. The sale is subject to regulatory approvals and is expected to be completed in the second half of 2019.

 

The sale consideration of €97.5 mn is payable in cash on completion.

 

On completion, the sale is expected to have a positive impact of c.30 bps1 on both the Group's CET1 ratio and Total Capital ratio. The carrying value of the Group's investment in CNP CIH was €119 mn as at 31 March 2019. The accounting loss from the sale is estimated at c.€22 mn1.

 

The sale enables the Group to focus on its core assets and is in line with the Group's strategy of delivering value for shareholders. The Group will continue to offer insurance services through its wholly owned insurance subsidiaries.

 

As required by the Cyprus Stock Exchange and according to paragraph 5.2.1.17(7) of the Decision of the Council of the CSE Concerning the CSE Market 379/2014 (as amended), the transaction is at arm's length, it does not relate to or affect the interests of the Company's Secretary or of any "designated person" in accordance with the meaning given to the aforementioned term in article 137(3) of the Cyprus Securities and Stock Exchange Law 14(I)/1993 (as amended).

 

Notes to the editor

 

CNP CIH is the parent company of a group of insurance companies in Cyprus and Greece. Specifically, CNP CIH is 100% shareholder in CNP Zois S.A. which offers life insurance services in Greece, CNP Asfalistiki Limited, which offers general insurance services in Cyprus, CNP Cyprialife Limited, which offers life insurance services in Cyprus and CNP Cyprus Properties Limited, an investment holding company in Cyprus.

 

For further information, please contact Investor Relations at investors@bankofcyprus.com.

 

 

1 Based on the Group financial results for the quarter ended 31 March 2019, pro forma for the sale of a portfolio of loans of €2.8 bn, known as Project Helix.

 

 

Group Profile

 

The Bank of Cyprus Group is the leading banking and financial services group in Cyprus, providing a wide range of financial products and services which include retail and commercial banking, finance, factoring, investment banking, brokerage, fund management, private banking, life and general insurance. The Bank of Cyprus Group operates through a total of 108 branches in Cyprus. Bank of Cyprus also has representative offices in Russia, Ukraine and China. The Bank of Cyprus Group employs 4,156 staff worldwide. At 31 March 2019, the Group's Total Assets amounted to €21.7 bn and Total Equity was €2.5 bn. The Bank of Cyprus Group comprises Bank of Cyprus Holdings Public Limited Company, its subsidiary Bank of Cyprus Public Company Limited and its subsidiaries.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DISFIMFTMBMMMRL
Date   Source Headline
26th May 20227:00 amRNSTR1 Notification - Eaton Vance
23rd May 202210:35 amRNSBoard and Board Committees Composition
23rd May 20227:17 amRNSResolutions of AGM- Replacement
20th May 202212:36 pmRNSResolutions of AGM
19th May 20227:02 amRNSDoc re. (1Q2022 Financial Results Presentation)
19th May 20227:00 amRNS1st Quarter Results
5th May 20229:47 amRNSDate of announcement of 1Q2022 FR
14th Apr 20221:06 pmRNSNotice of AGM
13th Apr 202212:41 pmRNSPDMR Transaction - Ioardanou
7th Apr 202212:53 pmRNSPillar 3 Disclosures for 2021
4th Apr 20227:27 amRNSTR1 Notification of Major Holdings- Caius
30th Mar 202210:57 amRNSPDMR Notification of Transaction – Iordanou
30th Mar 20227:05 amRNSBOC Annual Financial Report 2021 Announcement
30th Mar 20227:03 amRNSBOCH Annual Financial Report 2021 Announcement
30th Mar 20227:02 amRNSDoc re. (FY2021 Investor Presentation)
30th Mar 20227:00 amRNSFY2021 Group Financial Results
18th Mar 202211:46 amRNSNotice of Results
17th Mar 20229:37 amRNSRestrictive measures and sanctions against Russia
7th Mar 20224:41 pmRNSSecond Price Monitoring Extn
7th Mar 20224:36 pmRNSPrice Monitoring Extension
21st Feb 20227:02 amRNSDoc re. Prelim FY2021 Investor Presentation
21st Feb 20227:00 amRNSFY2021 Prel. Group FR and MT Strategic Targets
18th Feb 20228:22 amRNSTR1 Major Holdings Notification -Senvest
8th Feb 20227:00 amRNSDate of announcement of Preliminary Results 2021
13th Jan 20224:40 pmRNSSecond Price Monitoring Extn
13th Jan 20224:35 pmRNSPrice Monitoring Extension
17th Dec 20211:22 pmRNSCompletion of a small-scale targeted VEP
16th Dec 202110:27 amRNSDate of Annual General Meeting
6th Dec 20217:43 amRNSEU-wide Transparency Exercise 2021
1st Dec 20217:00 amRNSDecision to call Tier 2 Capital Notes
30th Nov 202111:51 amRNSAppointment of New Director
30th Nov 202110:32 amRNSGroup Financial Results for 9M2021 - Replacement
30th Nov 20217:04 amRNSDoc re. (9M2021 Presentation Announcement)
30th Nov 20217:00 amRNSGroup Financial Results for 9M2021
19th Nov 20218:25 amRNSDate of Announcement of 9M2021 FR
15th Nov 20217:00 amRNSAgreement for sale of a portfolio of NPLs
8th Nov 20214:41 pmRNSSecond Price Monitoring Extn
8th Nov 20214:36 pmRNSPrice Monitoring Extension
29th Oct 20214:35 pmRNSPrice Monitoring Extension
8th Oct 202112:10 pmRNSBuyback of Tier 2 Capital Notes
7th Oct 202111:57 amRNSAppointment of New Director
30th Sep 20218:32 amRNSTR-1 Notification- Caius
16th Sep 20217:33 amRNSTR-1 Notification -Senvest
13th Sep 202112:00 pmRNSTR-1 Notification - Carval
9th Sep 20214:41 pmRNSSecond Price Monitoring Extn
9th Sep 20214:36 pmRNSPrice Monitoring Extension
8th Sep 20214:40 pmRNSSecond Price Monitoring Extn
8th Sep 20214:36 pmRNSPrice Monitoring Extension
7th Sep 20219:13 amRNSTR-1 Notification - Caius
1st Sep 20218:39 amRNSDoc re. (1H2021 Investor Presentation)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.